| CPC 1–2 (n,%) | CPC 1–2 (n,%) | p-value | Adjusted OR | p-value |
---|---|---|---|---|---|
Yes, n = 89 | No, n = 359 | (95% CI) | |||
Age (years) |  < 0.001* |  |  | ||
 < 40 | 16 (18.0%) | 19 (5.3%) | |||
 40–60 | 30 (33.7%) | 92 (25.6%) | |||
 60–80 | 31 (34.8%) | 173 (48.2%) | |||
 > 80 | 12 (13.5%) | 75 (20.9%) | |||
Origin | 0.924 | Â | Â | ||
 OHCA | 73 (82.0%) | 296 (82.5%) | |||
 IHCA | 16 (18.0%) | 63 (17.5%) | |||
Gender, male | 63 (70.8%) | 223 (62.1%) | 0.128 | Â | Â |
DM | 25 (28.1%) | 158 (44.0%) | 0.006* | 0.53 (0.28–0.98) | 0.044* |
HTN | 48 (53.9%) | 199 (55.4%) | 0.799 | Â | Â |
CAD | 26 (29.2%) | 95 (26.5%) | 0.601 | Â | Â |
HF | 12 (13.5%) | 79 (22.0%) | 0.074 | Â | Â |
COPD | 4 (4.5%) | 48 (13.4%) | 0.019* | Â | Â |
ESRD | 7 (7.9%) | 51 (14.2%) | 0.157 | Â | Â |
Malignancy | 6 (6.7%) | 53 (14.8%) | 0.045* | 0.26 (0.09–0.71) | 0.009* |
Witness | 80 (89.9%) | 272 (75.8%) | 0.004* | Â | Â |
Bystander CPR | 71 (79.8%) | 222 (61.8%) | 0.001* | 2.88 (1.41–5.87) | 0.004* |
Cardiac etiology | 64 (71.9%) | 153 (42.6%) |  < 0.001* |  |  |
Initial rhythm |  < 0.001* |  |  < 0.001* | ||
 Asystole | 6 (6.7%) | 181 (50.4%) | Reference | ||
 PEA | 25 (28.1%) | 91 (25.3%) | 8.59 (3.18–23.24)* | ||
 VT/VF | 58 (65.2%) | 87 (24.2%) | 17.78 (6.45–48.95)* | ||
CPR duration (min) | 0.006* | Â | 0.008* | ||
 < 10 | 30 (33.7%) | 70 (19.5%) | Reference | ||
 Oct-20 | 28 (31.5%) | 99 (27.6%) | 0.46 (0.21–1.02) | ||
 20–30 | 17 (19.1%) | 84 (23.4%) | 0.28 (0.12–0.67)* | ||
 > 30 | 14 (15.7%) | 106 (29.5%) | 0.24 (0.10–0.62)* | ||
Epinephrine dosage (mg) |  < 0.001* |  | 0.015* | ||
 0–2 | 70 (78.7%) | 165 (46.0%) | Reference | ||
 2–4 | 11 (12.4%) | 98 (27.3%) | 0.33 (0.15–0.75)* | ||
 4–6 | 3 (3.4%) | 36 (10.0%) | 0.39 (0.10–1.50) | ||
 > 6 | 5 (5.6%) | 60 (16.7%) | 0.34 (0.11–1.07) | ||
ROSC SBP (mmHg) | 0.116 | Â | Â | ||
 < 100 | 15 (16.9%) | 94 (26.2%) | |||
 100–110 | 3 (3.4%) | 31 (8.6%) | |||
 110–120 | 9 (10.1%) | 30 (8.4%) | |||
 120–130 | 8 (9.0%) | 25 (7.0%) | |||
 > 130 | 54 (60.7%) | 179 (49.9%) | |||
ROSC DBP (mmHg) | 0.003* | Â | 0.091 | ||
 < 60 | 14 (15.7%) | 126 (35.1%) | Reference | ||
 60–70 | 13 (14.6%) | 56 (15.6%) | 1.17 (0.44–3.12) | ||
 70–80 | 12 (13.5%) | 47 (13.1%) | 2.33 (0.84–6.47) | ||
 80–90 | 14 (15.7%) | 40 (11.1%) | 2.20 (0.79–6.14) | ||
 > 90 | 36 (40.4%) | 90 (25.1%) | 2.73 (1.22–6.10)* | ||
ROSC MBP (mmHg) | 0.006* | Â | Â | ||
 < 80 | 18 (20.2%) | 130 (36.2%) | |||
 80–90 | 7 (7.9%) | 43 (12.0%) | |||
 90–100 | 20 (22.5%) | 49 (13.6%) | |||
 100–110 | 6 (6.7%) | 32 (8.9%) | |||
 > 110 | 38 (42.7%) | 105 (29.2%) | |||
PCI | 51 (57.3%) | 72 (20.1%) |  < 0.001* |  |  |